Literature DB >> 10865242

Chronic bronchitis in rural and industrial areas.

K I Gourgoulianis1, P Katikos, M Moraitis, N Argiriou, P A Molyvdas.   

Abstract

The purpose of the study was the determination of prevalence of chronic bronchitis in people older than 55 years in rural and industrial areas. 569 people over 55 years old living in central Greece were studied. A protocol was completed for each patient that included smoking habits, job, age, weight, drugs used for respiratory system and symptoms. A chest radiograph was taken for each patient. Each patient was submitted to three trials of dynamic spirometry. The best results were used for the study. The patients who complained of expectoration for three months for two continuous years and had obstructive pattern of lung function were diagnosed with chronic bronchitis. 9.6% of the subjects in rural area and 17.1% in industrial area were diagnosed with chronic bronchitis. Half the COPD patients never visited a doctor for this specific problem and were diagnosed for the first time. One out of three examined people had abnormal lung function. Consequently, more than one out of ten people older than 55 years have chronic bronchitis. Industrial exposure seems to double the risk for chronic bronchitis.

Entities:  

Mesh:

Year:  2000        PMID: 10865242

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  2 in total

1.  Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.

Authors:  Mohammed Al Ghobain; Mohamed S Al-Hajjaj; Siraj Omar Wali
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

2.  Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis.

Authors:  Evdoxia Gogou; Ourania S Kotsiou; Dimitra S Siachpazidou; Maria Pinaka; Charalampos Varsamas; Fotini Bardaka; Irini Gerogianni; Chrysi Hatzoglou; Konstantinos I Gourgoulianis
Journal:  NPJ Prim Care Respir Med       Date:  2021-03-12       Impact factor: 2.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.